#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	18208	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2042	884.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1387	1387	C	1055	C,A	972,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	18208	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2042	884.3	0	HET	.	.	.	A69G	.	69	69	A	272	272	A	1040	A,G	511,450	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33454	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3691	904.7	0	.	n	.	0	T695C	SNP	695	695	T	1123	1123	C	1019	C	954	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33454	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3691	904.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1765	1765	A	1093	A	1029	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33454	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3691	904.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2399	2399	C	1049	C	969	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33454	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3691	904.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2473	2473	A	1073	A,G,C	998,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	33454	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3691	904.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3025	3025	C	1028	C,A	965,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2500	folP	855	855	100.0	folP.l6.c30.ctg.1	1614	154.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1065	1067	AGC	287;284;288	A;G;C	264;259;262	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6310	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3440	182.8	1	SNP	p	S91F	1	.	.	271	273	TTC	628	630	TTC	210;207;210	T;T;C	188;185;188	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6310	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3440	182.8	1	SNP	p	D95G	1	.	.	283	285	GGC	640	642	GGC	203;203;203	G;G,A;C	187;187,1;186	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6310	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3440	182.8	1	SNP	p	G95N	0	.	.	283	285	GGC	640	642	GGC	203;203;203	G;G,A;C	187;187,1;186	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	2056	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1363	150.5	1	SNP	p	G45D	0	.	.	133	135	GGC	495	497	GGC	257;257;255	G;G;C	239;238;237	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1062	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1164	91.1	0	.	n	.	0	A197.	DEL	197	197	A	615	615	A	255	A	236	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6222	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2873	215.6	1	SNP	p	D86N	0	.	.	256	258	GAC	488	490	GAC	267;265;267	G,T;A;C	249,2;244;253	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6222	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2873	215.6	1	SNP	p	S87R	1	.	.	259	261	CGT	491	493	CGT	271;272;276	C,A;G;T,C,A	256,1;257;258,1,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6222	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2873	215.6	1	SNP	p	R87W	0	.	.	259	261	CGT	491	493	CGT	271;272;276	C,A;G;T,C,A	256,1;257;258,1,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6222	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2873	215.6	1	SNP	p	R87I	0	.	.	259	261	CGT	491	493	CGT	271;272;276	C,A;G;T,C,A	256,1;257;258,1,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6222	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2873	215.6	1	SNP	p	S88P	0	.	.	262	264	TCC	494	496	TCC	275;277;279	T;C;C	260;264;266	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5196	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2495	207.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1492	1494	GGC	243;244;240	G;G,A;C	222;221,1;218	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2422	194.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1246	1248	GCA	236;239;239	G,A;C;A	215,1;224;227	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2422	194.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1249	1251	ATC	238;240;242	A;T;C	226;227;230	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2422	194.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1261	1263	GTG	249;247;249	G;T;G	234;231;234	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2422	194.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1261	1263	GTG	249;247;249	G;T;G	234;231;234	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2422	194.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1765	1767	ACC	225;223;225	A;C;C,T	201;206;203,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2422	194.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1819	1821	GCG	226;224;223	G;C,G;G	196;176,1;183	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2422	194.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1819	1821	GCG	226;224;223	G;C,G;G	196;176,1;183	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2422	194.7	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1942	1944	AGC	205;204;203	A;G;C	193;192;190	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2422	194.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1951	1953	GGC	200;202;203	G;G;C	185;188;187	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4734	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2422	194.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1969	1971	CCG	191;193;194	C,G;C,A;G	130,4;129,1;136	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6956	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3098	223.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1673	1675	CCG	266;265;263	C,A;C;G	247,1;253;248	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2684	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1714	155.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	435	435	C	164	C	146	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	410	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	547	37.0	0	.	p	.	0	M18T	NONSYN	52	54	ATG	456	458	ACG	93;90;88	A;C;G	84;82;82	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	410	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	547	37.0	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	498	500	CAA	50;49;40	C;A;A	44;43;36	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	410	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	547	37.0	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	504	506	TAC	30;29;29	T;A;C	28;28;28	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3424	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1685	202.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	488	490	GAA	276;276;276	G;A;A	260;262;262	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3424	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1685	202.7	0	.	p	.	0	N134D	NONSYN	400	402	AAT	776	778	GAT	264;262;265	G;A;T	245;242;247	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3424	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1685	202.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	899	901	TCA	316;317;318	T;C;A	293;293;294	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3424	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1685	202.7	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1028	1030	GTC	283;283;284	G;T;C	263;259;266	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3424	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1685	202.7	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1040	1042	TCT	275;274;277	T;C;T	262;265;264	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3424	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1685	202.7	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1358	1360	GCA	276;275;275	G;C,T;A	254;253,1;253	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3424	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1685	202.7	1	SNP	p	G120K	1	.	.	358	360	AAG	734	736	AAG	260;261;264	A;A;G	241;242;244	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3424	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1685	202.7	1	SNP	p	D121N	0	.	.	361	363	GAC	737	739	GAC	264;260;257	G;A;C	243;240;239	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3424	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1685	202.7	1	SNP	p	A121D	1	.	.	361	363	GAC	737	739	GAC	264;260;257	G;A;C	243;240;239	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	418	porB3	990	116	92.24	porB3.l15.c30.ctg.2	532	30.5	0	.	p	.	0	M18T	NONSYN	52	54	ATG	456	458	ACG	71;68;65	A;C;G	65;63;62	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	418	porB3	990	116	92.24	porB3.l15.c30.ctg.2	532	30.5	0	.	p	.	0	T29A	NONSYN	85	87	ACC	489	491	GCC	65;63;60	G;C;C	58;56;53	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	418	porB3	990	116	92.24	porB3.l15.c30.ctg.2	532	30.5	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	498	500	CAA	45;44;35	C;A;A	39;38;31	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	418	porB3	990	116	92.24	porB3.l15.c30.ctg.2	532	30.5	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	504	506	TAC	25;24;24	T;A;C	23;23;23	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12540	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4934	253.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1328	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1053	125.7	1	SNP	p	V57M	1	.	.	169	171	ATG	527	529	ATG	292;294;294	A;T;G	271;272;271	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
